Dyne Therapeutics, Inc.

DYN · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Assets
Cash & Equivalents$573,610$485,040$472,255$435,449
Short-Term Investments$218,277$198,885$205,237$206,819
Receivables$0$0$0$0
Inventory$0$0$0$0
Other Curr. Assets$14,376$14,025$12,011$17,011
Total Curr. Assets$806,263$697,950$689,503$659,279
Property Plant & Equip (Net)$45,790$28,534$29,629$30,013
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$0$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$15,006$2,508$1,942$1,942
Total NC Assets$60,796$31,042$31,571$31,955
Other Assets$0$0$0$0
Total Assets$867,059$728,992$721,074$691,234
Liabilities
Payables$12,061$14,016$7,019$6,562
Short-Term Debt$5,039$5,002$5,111$4,850
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$42,749$22,454$21,752$30,846
Total Curr. Liab.$59,849$41,472$33,882$42,258
LT Debt$16,280$116,075$18,219$19,138
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$99,147$0$0$0
Total NC Liab.$115,427$116,075$18,219$19,138
Other Liabilities$0$0$0$0
Cap. Leases$0$22,264$23,330$23,988
Total Liabilities$175,276$157,547$52,101$61,396
Equity
Pref Stock$0$0$0$0
Common Stock$14$11$11$10
Retained Earnings-$1,284,187-$1,176,146-$1,065,289-$949,928
AOCI$496$252$241$6
Other Equity$1,975,460$1,747,328$1,734,010$1,579,750
Total Equity$691,783$571,445$668,973$629,838
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$867,059$728,992$721,074$691,234
Net Debt-$552,291-$363,963-$448,925-$411,461
Dyne Therapeutics, Inc. (DYN) Financial Statements & Key Stats | AlphaPilot